Diaceutics PLC (LON:DXRX) Insider Graham Paterson Purchases 39,934 Shares

Diaceutics PLC (LON:DXRX) insider Graham Paterson bought 39,934 shares of the firm’s stock in a transaction that occurred on Wednesday, May 22nd. The stock was bought at an average price of GBX 129 ($1.64) per share, with a total value of £51,514.86 ($65,473.89).

Graham Paterson also recently made the following trade(s):

• On Wednesday, March 6th, Graham Paterson bought 33,564 shares of Diaceutics stock. The stock was bought at an average price of GBX 99 ($1.26) per share, with a total value of £33,228.36 ($42,232.28).

Diaceutics Price Performance

Diaceutics stock opened at GBX 127.50 ($1.62) on Friday. Diaceutics PLC has a 1-year low of GBX 79 ($1.00) and a 1-year high of GBX 129 ($1.64). The company has a debt-to-equity ratio of 3.07, a current ratio of 7.99 and a quick ratio of 9.92. The stock has a market cap of £107.97 million, a PE ratio of 10,500.00 and a beta of 0.47. The stock’s fifty day moving average is GBX 104.65 and its two-hundred day moving average is GBX 96.90.

Analysts Set New Price Targets

Separately, Canaccord Genuity Group reiterated a “buy” rating and issued a GBX 150 ($1.91) target price on shares of Diaceutics in a report on Tuesday.

Diaceutics Company Profile

Diaceutics PLC, a diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It operates DXRX platform, which offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories that provides DXRX signal, lab mapping, testing dashboard, and physician mapping services; DXRX marketplace solutions, which enables a marketplace, where labs, pharma, and diagnostic companies come to find partners for collaborations on precision medicine diagnostics.